TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 2193276

Group type: EXPERIMENTAL
Intervention: Monitoring contraction rate at home (threshold of at least four contractions per hour)
Number of subjects: 105
Study: 526527

Group type: EXPERIMENTAL
Intervention: Different sets of treatments
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Increased sample size
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Weighted randomization
Number of subjects: 0
Study: 31411695

Group type: EXPERIMENTAL
Intervention: Eculizumab
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control
Number of subjects: 54
Study: 30253697

Group type: EXPERIMENTAL
Intervention: Tribulus terrestris (3 times daily for 3 months)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 29249805

Group type: EXPERIMENTAL
Intervention: rTMS + ADP
Number of subjects: 281

Group type: EXPERIMENTAL
Intervention: rTMS
Number of subjects: 281

Group type: COMPARATOR
Intervention: ADP
Number of subjects: 281
Study: 26934401

Group type: EXPERIMENTAL
Intervention: Resistance exercise
Number of subjects: 34

Group type: COMPARATOR
Intervention: Conventional physical therapy (Control)
Number of subjects: 34
Study: 25132459

Group type: EXPERIMENTAL
Intervention: 1000 mg i.v. paracetamol
Number of subjects: 120

Group type: COMPARATOR
Intervention: Sterile water (placebo)
Number of subjects: 120
Study: 22935339

Group type: EXPERIMENTAL
Intervention: Fixed snack regimen (2 snacks, fed 4 hours apart)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Variable snack regimen (2 snacks based on body surface area, fed 4 hours apart)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Both fixed and variable snacks
Number of subjects: 10
Study: 19683638

Group type: EXPERIMENTAL
Intervention: Tight control (target systolic blood pressure < 130 mm Hg)
Number of subjects: 1111

Group type: COMPARATOR
Intervention: Usual control (target systolic blood pressure < 140 mm Hg)
Number of subjects: 1111

Group type: EXPERIMENTAL
Intervention: Tight control
Number of subjects: 1111

Group type: COMPARATOR
Intervention: Usual control
Number of subjects: 1111
Study: 17295580

Group type: EXPERIMENTAL
Intervention: Supportive-expressive psychotherapy
Number of subjects: 75

Group type: COMPARATOR
Intervention: Sertraline
Number of subjects: 75

Group type: COMPARATOR
Intervention: Pill placebo
Number of subjects: 75

Group type: COMPARATOR
Intervention: Active medication (Sertraline)
Number of subjects: 75
Study: 15895833

Group type: EXPERIMENTAL
Intervention: Glutamate injections (1.0 mol/L)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Isotonic saline injections (0.165 mol/L)
Number of subjects: 26
Study: 12795239

Group type: EXPERIMENTAL
Intervention: 0.15 mg/kg i.v. bolus
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: 0.04 mg/kg i.m. injection
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: 0.04 mg/kg i.v. infusion
Number of subjects: 28
Study: 9578931

Group type: EXPERIMENTAL
Intervention: Combined ipratropium bromide (0.06% two sprays per nostril) and oxymetazoline (0.05% two sprays per nostril)
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Oxymetazoline alone
Number of subjects: 109

Group type: COMPARATOR
Intervention: Vehicle (placebo)
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Combined ipratropium bromide and oxymetazoline
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 109
Study: 7643883

Group type: EXPERIMENTAL
Intervention: Bivalirudin
Number of subjects: 4098
Study: 2794470

Group type: EXPERIMENTAL
Intervention: Carbamazepine (CBZ)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Haloperidol (HP)
Number of subjects: 17
Study: 385100

Group type: EXPERIMENTAL
Intervention: Cimetidine, 1.6 g daily for six months
Number of subjects: 20

Group type: COMPARATOR
Intervention: Matching placebo for six months
Number of subjects: 20
Study: 29697291

Group type: EXPERIMENTAL
Intervention: Vildagliptin (vild) plus standard medical treatment
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard medical treatment
Number of subjects: 60
Study: 27527256

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin for four months
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 24885124

Group type: EXPERIMENTAL
Intervention: Automated FiO2-SpO2 control system with a control range of 87-93% SpO2
Number of subjects: 21

Group type: COMPARATOR
Intervention: Automated FiO2-SpO2 control system with a control range of 90-93% SpO2
Number of subjects: 21
Study: 22879314

Group type: EXPERIMENTAL
Intervention: basic fibroblast growth factor (bFGF) treatment
Number of subjects: 20

Group type: COMPARATOR
Intervention: impregnated gauze treatment (control)
Number of subjects: 20
Study: 20174819

Group type: EXPERIMENTAL
Intervention: Self-fixating Parietene progrip mesh (group A)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Traditional Lichtenstein repair (group B)
Number of subjects: 50
Study: 18362422

Group type: EXPERIMENTAL
Intervention: Pitavastatin (1 or 2 mg/day)
Number of subjects: 30

Group type: COMPARATOR
Intervention: No statin therapy
Number of subjects: 30
Study: 15383370

Group type: EXPERIMENTAL
Intervention: rhIL-6 infusion for 3 hours
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: rhIL-6 infusion
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: IL-6 treatment alone
Number of subjects: 2

Group type: COMPARATOR
Intervention: IL-6 plus dexamethasone and GH
Number of subjects: 2

Group type: COMPARATOR
Intervention: IL-6 and AICAR
Number of subjects: 2
Study: 12433762

Group type: EXPERIMENTAL
Intervention: Bezafibrate 400 mg daily
Number of subjects: 1568

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1568
Study: 11221128

Group type: EXPERIMENTAL
Intervention: Information programme and distribution of female and male condoms at intervention sites
Number of subjects: 1929

Group type: COMPARATOR
Intervention: Male condoms only and similar information about them at control sites
Number of subjects: 1929
Study: 8997654

Group type: EXPERIMENTAL
Intervention: Toothpaste containing 1.5% SLS and 0.3% triclosan
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Toothpaste containing 3% SLS and 0.3% triclosan
Number of subjects: 0

Group type: COMPARATOR
Intervention: Positive control toothpaste containing 1.5% SLS without triclosan
Number of subjects: 0
Study: 1984942

Group type: EXPERIMENTAL
Intervention: TF‐IMT (PR + IMT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: PR (Control)
Number of subjects: 40
Study: 6624851

Group type: EXPERIMENTAL
Intervention: Oral habilitation program (sensorimotor facilitation procedures)
Number of subjects: 4
Study: 30615947

Group type: EXPERIMENTAL
Intervention: ADF and exercise (E‐ADF)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 112

Group type: COMPARATOR
Intervention: Control
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: ADF
Number of subjects: 112
Study: 29321340

Group type: EXPERIMENTAL
Intervention: ABC/2.4 method
Number of subjects: 390

Group type: EXPERIMENTAL
Intervention: ABC/3 method
Number of subjects: 390

Group type: EXPERIMENTAL
Intervention: ABC/2 method
Number of subjects: 390

Group type: EXPERIMENTAL
Intervention: Semiautomatic segmentation
Number of subjects: 390
Study: 27116282

Group type: EXPERIMENTAL
Intervention: Pathogen-reduced whole blood (treated)
Number of subjects: 226

Group type: COMPARATOR
Intervention: Standard untreated whole blood (untreated)
Number of subjects: 226
Study: 25588906

Group type: EXPERIMENTAL
Intervention: 3D spiral sequence (GE)
Number of subjects: 22

Group type: COMPARATOR
Intervention: 2D EPI sequence (Philips)
Number of subjects: 22
Study: 23116500

Group type: EXPERIMENTAL
Intervention: Orthodontic miniscrew implants
Number of subjects: 2281
Study: 20022431

Group type: EXPERIMENTAL
Intervention: Pharmacological analgesia with low-cost VR system (eMagin Z800 3DVisor)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Pharmacological analgesia without VR system
Number of subjects: 11
Study: 18532969

Group type: EXPERIMENTAL
Intervention: Cerclage suture
Number of subjects: 78

Group type: COMPARATOR
Intervention: Cautery
Number of subjects: 78
Study: 16491691

Group type: EXPERIMENTAL
Intervention: Cup-stacking instructional unit (3 weeks)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Standard physical education curriculum
Number of subjects: 69
Study: 11815967

Group type: EXPERIMENTAL
Intervention: High-dose-rate (HDR) intracavitary radiation therapy
Number of subjects: 132

Group type: COMPARATOR
Intervention: Low-dose-rate (LDR) intracavitary radiation therapy
Number of subjects: 132
Study: 10431991

Group type: EXPERIMENTAL
Intervention: Elastic compression
Number of subjects: 562

Group type: EXPERIMENTAL
Intervention: Saphenous ligation
Number of subjects: 562

Group type: EXPERIMENTAL
Intervention: Stripping of the affected veins
Number of subjects: 562

Group type: COMPARATOR
Intervention: Compression alone
Number of subjects: 562

Group type: EXPERIMENTAL
Intervention: Low-molecular-weight heparin (LMWH)
Number of subjects: 562

Group type: EXPERIMENTAL
Intervention: Oral anticoagulant (OC) treatment
Number of subjects: 562

Group type: EXPERIMENTAL
Intervention: Low-dose subcutaneous heparin (LDSH)
Number of subjects: 562
Study: 7595068

Group type: EXPERIMENTAL
Intervention: Diet high in stearic acid (C18)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Diet high in palmitic acid (C16)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Diet high in myristic+lauric acid (C12+C14)
Number of subjects: 27
Study: 2209889

Group type: EXPERIMENTAL
Intervention: Dummy embryo transfer (ET)
Number of subjects: 335

Group type: COMPARATOR
Intervention: No dummy embryo transfer (Control)
Number of subjects: 335
Study: 7051739

Group type: EXPERIMENTAL
Intervention: Tolfenamic acid
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 31102063

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 431

Group type: EXPERIMENTAL
Intervention: CBT + Fluoxetine (COMB)
Number of subjects: 431

Group type: COMPARATOR
Intervention: Interpersonal Psychotherapy for Adolescents (IPT-A)
Number of subjects: 431
Study: 28850367

Group type: EXPERIMENTAL
Intervention: 50mg mavatrep
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: 500mg naproxen
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study: 26184461

Group type: EXPERIMENTAL
Intervention: risperidone long acting injection
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: flupenthixol decanoate
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (matched healthy volunteers)
Number of subjects: 22
Study: 24819857

Group type: EXPERIMENTAL
Intervention: Topical timolol‐dorzolamide fixed‐combination drops twice daily when IOP exceeded 10 mmHg
Number of subjects: 94

Group type: COMPARATOR
Intervention: Conventional stepwise treatment when IOP exceeded target pressure
Number of subjects: 94
Study: 21978930

Group type: EXPERIMENTAL
Intervention: Support-based smoking cessation intervention
Number of subjects: 0
Study: 19296033

Group type: EXPERIMENTAL
Intervention: Peer-adult-led intervention (four-hour group session)
Number of subjects: 530

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 530

Group type: EXPERIMENTAL
Intervention: Peer-adult-led intervention
Number of subjects: 530
Study: 21357960

Group type: EXPERIMENTAL
Intervention: Fourier transform infrared spectroscopy (FTIR) analysis of torn rotator cuff tendons
Number of subjects: 81

Group type: COMPARATOR
Intervention: Fourier transform infrared spectroscopy (FTIR) analysis of uninjured control tendons
Number of subjects: 81
Study: 16136765

Group type: EXPERIMENTAL
Intervention: Etoricoxib (120 mg)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Celecoxib (200 mg)
Number of subjects: 58
Study: 12271371

Group type: EXPERIMENTAL
Intervention: Topical anesthesia (oxybutynin 0.4% eye drops and cocaine hydrochloride 10% eye drops)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Retrobulbar anesthesia (5 ml mepivacaine 2% injected into the retrobulbar space)
Number of subjects: 20
Study: 10397541

Group type: EXPERIMENTAL
Intervention: Individualized, unrestricted antiretroviral therapy
Number of subjects: 173
Study: 8642546

Group type: EXPERIMENTAL
Intervention: Inositol 6 g daily for 5 days before the 5th or 6th ECT
Number of subjects: 0
Study: 2197098

Group type: EXPERIMENTAL
Intervention: Atenolol 100 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Quinapril 40 mg
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 7389356

Group type: EXPERIMENTAL
Intervention: Estradiol cypionate
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Estradiol valerate
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Estradiol benzoate
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control (no specific control group mentioned)
Number of subjects: 29
Study: 28691541

Group type: EXPERIMENTAL
Intervention: Hazelnuts
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Hazelnut-Cocoa
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Peeled Hazelnut Snack
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Hazelnut-Cocoa Integration
Number of subjects: 61
Study: 27648000

Group type: EXPERIMENTAL
Intervention: Non-DM group
Number of subjects: 80

Group type: COMPARATOR
Intervention: DM group
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 80
Study: 23278375

Group type: EXPERIMENTAL
Intervention: Immediate loading implants (test)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Early loaded implants (control)
Number of subjects: 12
Study: 22607887

Group type: EXPERIMENTAL
Intervention: Early invasive therapy
Number of subjects: 246

Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 246
Study: 20367770

Group type: EXPERIMENTAL
Intervention: Dapoxetine 30 mg
Number of subjects: 1162

Group type: EXPERIMENTAL
Intervention: Dapoxetine 60 mg
Number of subjects: 1162

Group type: EXPERIMENTAL
Intervention: Dapoxetine (30 mg or 60 mg)
Number of subjects: 1162

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1162
Study: 18195564

Group type: EXPERIMENTAL
Intervention: Trizivir plus efavirenz
Number of subjects: 209

Group type: EXPERIMENTAL
Intervention: Trizivir plus lopinavir/ritonavir
Number of subjects: 209

Group type: COMPARATOR
Intervention: Control group (not explicitly defined)
Number of subjects: 209
Study: 15516345

Group type: EXPERIMENTAL
Intervention: Levobupivacaine
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Ropivacaine
Number of subjects: 41
Study: 12027842

Group type: EXPERIMENTAL
Intervention: NDS (fresh gas flow of 1 litre/min without additional dead-space volumes)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: DS + 1.0 (fresh gas flow of 1 litre/min with additional dead-space volumes)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: DS + 0.5 (fresh gas flow of 0.5 litre/min with additional dead-space volumes)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: DS + 1.0
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: DS + 0.5
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: DS groups
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 45
Study: 10444053

Group type: EXPERIMENTAL
Intervention: Diagnostic RGP bitoric lens
Number of subjects: 0

Group type: COMPARATOR
Intervention: Diagnostic PMMA spherical lens
Number of subjects: 0
Study: 7851590

Group type: EXPERIMENTAL
Intervention: Tubal transfer of cryopreserved embryos
Number of subjects: 40

Group type: COMPARATOR
Intervention: Uterine transfer of cryopreserved embryos
Number of subjects: 40
Study: 1723550

Group type: COMPARATOR
Intervention: KRN 8601 (75 micrograms/body, subcutaneous administration)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: KRN 8601 (25-800 micrograms/m2)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: KRN 8601 (100-200 micrograms/m2, intravenous drip infusion)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Inactive placebo
Number of subjects: 0
Study: 7195890

Group type: EXPERIMENTAL
Intervention: Medical treatment
Number of subjects: 71

Group type: COMPARATOR
Intervention: Surgical-medical treatment (internal urethrotomy with antimicrobial agents)
Number of subjects: 71
Study: 30660634

Group type: EXPERIMENTAL
Intervention: Supine Position (SP)
Number of subjects: 347
Study: 28762023

Group type: EXPERIMENTAL
Intervention: PVI group
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study: 26372552

Group type: EXPERIMENTAL
Intervention: Cannulated screw group (n = 16 patients, 16 feet)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Plate group (n = 15 patients, 16 feet)
Number of subjects: 31
Study: 24530651

Group type: EXPERIMENTAL
Intervention: ForeseeHome (FH) device plus standard care
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 0
Study: 23208165

Group type: EXPERIMENTAL
Intervention: Interactive computer alerts for virologic failure and abnormal laboratory test results
Number of subjects: 1011

Group type: COMPARATOR
Intervention: Static alerts for virologic failure and abnormal laboratory test results
Number of subjects: 1011

Group type: EXPERIMENTAL
Intervention: Interactive computer alerts for suboptimal follow-up
Number of subjects: 1011

Group type: COMPARATOR
Intervention: Static alerts for suboptimal follow-up
Number of subjects: 1011

Group type: EXPERIMENTAL
Intervention: Interactive computer alerts after suboptimal follow-up alert
Number of subjects: 1011

Group type: COMPARATOR
Intervention: Static alerts after suboptimal follow-up alert
Number of subjects: 1011

Group type: EXPERIMENTAL
Intervention: Interactive computer alerts after toxicity alert
Number of subjects: 1011

Group type: COMPARATOR
Intervention: Static alerts after toxicity alert
Number of subjects: 1011
Study: 20051377

Group type: EXPERIMENTAL
Intervention: Sulindac 150 mg daily for 6 weeks
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Sulindac 150 mg twice daily for 6 weeks
Number of subjects: 30
Study: 18931209

Group type: EXPERIMENTAL
Intervention: Cobra Perilaryngeal Airway (PLA)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Laryngeal Mask Airway (LMA)
Number of subjects: 200
Study: 16098887

Group type: EXPERIMENTAL
Intervention: Non-nutritive sucking (NNS)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group (no NNS)
Number of subjects: 44
Study: 12587520

Group type: EXPERIMENTAL
Intervention: Fluvoxamine (25 to 125 mg daily)
Number of subjects: 31
Study: 9656160

Group type: EXPERIMENTAL
Intervention: Oral administration of coumarin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Parenteral administration of coumarin
Number of subjects: 0
Study: 8122728

Group type: EXPERIMENTAL
Intervention: Short donation intervals (days 0, 3, 7, and 14)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Weekly donation intervals
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Short donation intervals (group I)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Weekly donation intervals (group II)
Number of subjects: 40
Study: 2548815

Group type: EXPERIMENTAL
Intervention: Nedocromil sodium (4 mg twice daily by inhalation)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 69
Study: 956443

Group type: EXPERIMENTAL
Intervention: 16 hour marathon group conducted by a female leader team
Number of subjects: 25

Group type: COMPARATOR
Intervention: No treatment control group
Number of subjects: 25
Study: 31477797

Group type: COMPARATOR
Intervention: Yogurt consumption 1 time/week
Number of subjects: 24389

Group type: COMPARATOR
Intervention: Yogurt consumption 2-3 times/week
Number of subjects: 24389

Group type: COMPARATOR
Intervention: Yogurt consumption ≥4 times/week
Number of subjects: 24389
Study: 31421685

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 74

Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 74
Study: 27720794

Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Stress Reduction for Breast Cancer (MBSR(BC)) program
Number of subjects: 322

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 322
Study: 25666288

Group type: EXPERIMENTAL
Intervention: Single intraoperative dose of 30 mg/kg tranexamic acid (OS group)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Loading dose of 10 mg/kg tranexamic acid followed by continuous 2 mg/kg/h infusion for 20 h (OD group)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Both groups (OS and OD)
Number of subjects: 106
Study: 23480644

Group type: EXPERIMENTAL
Intervention: Hand training for 12 weeks
Number of subjects: 35

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 35
Study: 21752319

Group type: EXPERIMENTAL
Intervention: Flexible bronchoscopy plus conventional medical treatment (lavage group)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional medical treatment (control group)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Flexible bronchoscopy (lavage group)
Number of subjects: 60
Study: 18810487

Group type: EXPERIMENTAL
Intervention: Perceiving a tone repetition
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Salient action effects
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-salient action effects
Number of subjects: 0
Study: 17077079

Group type: EXPERIMENTAL
Intervention: Probiotic combination (L. rhamnosus GG, L. rhamnosus Lc705, P. freudenreichii ssp. shermanii JS, Bifidobacterium breve Bb99)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 15001966

Group type: EXPERIMENTAL
Intervention: 600 mg rifampin for 6 days
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 11510872

Group type: EXPERIMENTAL
Intervention: Constant incline-based protocol
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Constant speed-based protocol
Number of subjects: 8

Group type: COMPARATOR
Intervention: Both protocols
Number of subjects: 8

Group type: COMPARATOR
Intervention: Higher inclines
Number of subjects: 8
Study: 10405564

Group type: EXPERIMENTAL
Intervention: Patients with hypertension and cerebral stroke
Number of subjects: 36

Group type: COMPARATOR
Intervention: Patients with primary hypertension without cerebral stroke (control group)
Number of subjects: 36
Study: 8297699

Group type: EXPERIMENTAL
Intervention: Epoprostenol (PGI2)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 135
Study: 2465710

Group type: EXPERIMENTAL
Intervention: Mivacurium 0.15 mg/kg
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Mivacurium 0.20 mg/kg
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Mivacurium 0.25 mg/kg
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study: 31402434

Group type: EXPERIMENTAL
Intervention: Web-based intervention (WI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Enhanced usual care condition
Number of subjects: 0